Describing the Elephant in the Room

 Describing the Elephant in the Room

As I prepared to relaunch Tablets & Capsules with my CompareNetworks colleagues, I was reminded of the ancient Indian parable of the blind men and the elephant. Each touched a diff erent part. The man who grabbed the tail called it a rope. The man who patted the trunk dubbed it a snake. And the man who tapped a leg labelled it a tree.

The Oral Solid Dose community can appear similarly disparate, depending on one’s position and perspective. Its parts include regulatory aff airs, manufacturing, research, and formulation among many others. It can be easy to stay in one’s own area of expertise, but I’m learning how one part informs another. In this issue, for instance the “Eye on Excipients” column suggests how one interprets regulatory aff airs on co-processed excipients in one part of the world could impact formulation—and, downstream, potentially, a host of manufacturing processes—in another.

I’ve written about science from many perspectives—policy, career, and basic and clinical research. I’m excited to take on another. And I’m thrilled to draw on the wide varieties of expertise in this exciting fi eld. In doing so, I consider it Tablets & Capsules’ mission to serve every part of the OSD community.

Paul Smaglik

Editor Tablets & Capsules

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers from Tablets & Capsules – all delivered right to your inbox! Sign up now!